Regulations & Compliance STREAM
-
Moving In Unison: Proprietary Scheduling Platform
6/18/2024
Join us for an exclusive discussion that uncovers the science behind our efficient management of key sponsor deliverables and critical milestones, driving our projects to success.
-
Exploring The Principles Integral To Rare Disease Drug Development
6/12/2024
This on-demand webinar offers valuable insights into successful rare disease drug development, including study design, regulatory engagement, and market access strategy.
-
Plain Language Summaries Becoming A Mandate Worldwide
6/13/2024
A growing number of countries are requiring clinical trial protocol and results disclosures to be written in plain language, influencing how these documents are authored.
-
Is EU CTR Driving Tighter Clinical & Regulatory Integration?
3/31/2022
The new Clinical Trials Regulation (EU) 536/2014 has raised critical questions about business process and data interactions between Clinical and Regulatory in biopharmaceutical companies. Did you know that as of 6 March 2022, there were more than 200 draft applications in CTIS?
-
The Benefits Of Conducting A Clinical Trial In Canada
9/19/2023
Watch this video in which Altasciences’ regulatory experts share key insights on Health Canada’s Clinical Trial Application (CTA) regulatory submission process.
-
3 FDA Approvals In 2025 That Shift The Landscape For 2026
1/20/2026
In this presentation, Precision’s Chief Medical Officer and former FDA Director, Division of Oncology 2, Harpreet Singh, MD breaks down 3 FDA approvals from last year that are impacting 2026.
-
The Journey From File To Trial: Automating Regulatory To TMF
2/9/2021
In this webinar, we explore the value of automation between the Trial Master File (TMF) and Regulatory solutions. This connection can bridge the gap from the clinical trial to the regulatory filing, ensuring consistency of information while reducing duplicated data entry.
-
Ensuring Compliance In Gene Therapy Trials: IRB And IBC Views
9/23/2025
Explore ethical and regulatory challenges in neurological gene therapy trials, with expert insights on IRB/IBC collaboration, consent protocols, and oversight for vulnerable populations.
-
How To Take Advantage Of Early Access Programs For The EU
6/12/2024
Learn how to leverage Early Access Programs (EAPs) in the EU to expedite market entry for innovative life science products. Gain insights into running successful EAPs, including crucial steps for France.
-
Unlock The Secrets Of Managing CTR In A Complex Development Landscape
8/29/2024
Lost in the CTR maze? Watch this webinar to get your burning questions answered by industry experts. Ask about vendor coordination, CTIS integration, and EU strategies.